Phillips, Kelly-Anne <br/><br/>
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2013 
 - 3091-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2012.47.8313  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Breast Neoplasms--genetics<br/>Estrogen Antagonists--therapeutic use<br/>Female<br/>Genes, BRCA1<br/>Genes, BRCA2<br/>Heterozygote<br/>Humans<br/>Middle Aged<br/>Mutation<br/>Proportional Hazards Models<br/>Risk Factors<br/>Tamoxifen--therapeutic use